Polar Capital Holdings PLC Intra Cellular Therapies, Inc. Transaction History

Polar Capital Holdings PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$46.37 - $73.65 $3.3 Million - $5.25 Million	-71,255 Reduced 7.13%	928,745 $66.5 Million
Q3 2023 Nov 14, 2023	BUY	$52.09 - $64.1 $31.3 Million - $38.5 Million	600,000 Added 150.0%	1,000,000 $52.1 Million
Q1 2023 Dec 13, 2023	SELL	$43.8 - $56.99 $26.3 Million - $34.2 Million	-600,000 Reduced 60.0%	400,000 $21.7 Million
Q1 2023 May 15, 2023	SELL	$43.8 - $56.99 $2.13 Million - $2.77 Million	-48,580 Reduced 10.83%	400,000 $21.7 Million
Q4 2022 Feb 14, 2023	SELL	$44.07 - $54.45 $6.86 Million - $8.48 Million	-155,670 Reduced 25.76%	448,580 $23.7 Million
Q3 2022 Nov 14, 2022	SELL	$42.7 - $59.99 $12.1 Million - $17.1 Million	-284,287 Reduced 31.99%	604,250 $28.1 Million
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $15.8 Million - $24.1 Million	367,094 Added 70.4%	888,537 $50.7 Million
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $16.6 Million - $26.7 Million	429,708 Added 468.42%	521,443 $31.9 Million
Q3 2021 Nov 15, 2021	BUY	$28.72 - $42.49 $956,117 - $1.41 Million	33,291 Added 56.96%	91,735 $3.42 Million
Q2 2021 Aug 16, 2021	BUY	$29.3 - $44.5 $1.71 Million - $2.6 Million	58,444 New	58,444 $2.39 Million
Q1 2021 May 17, 2021	SELL	$30.8 - $39.51 $325,186 - $417,146	-10,558 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$23.34 - $32.22 $246,423 - $340,178	10,558 New	10,558 $336,000

381

84M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $11.9B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.